Company News in the Life Science Industry

»

Reset 

AVROBIO, Inc. Announces Pricing of Initial Public Offering

Read more ››
By: Nasdaq / GlobenewsWire - 21 Jun 2018

Rhythm Pharmaceuticals, Inc. Announces Pricing of Public Offering

Read more ››
By: Nasdaq / GlobenewsWire - 21 Jun 2018

Addex Shareholders Approve All Resolutions at Annual General Meeting

Read more ››
By: Nasdaq / GlobenewsWire - 21 Jun 2018

Bone Therapeutics SA: The preliminary documents for the Extraordinary General Shareholder Meeting on 9 July 2018 have been made available

Read more ››
By: Nasdaq / GlobenewsWire - 21 Jun 2018

ThromboGenics Partners with Prevent Blindness at 2018 Focus on Eye Health National Summit in Washington DC

Read more ››
By: Nasdaq / GlobenewsWire - 21 Jun 2018

Shire Announces FDA Approval for Label Expansion of CINRYZE® for Prevention of Attacks in Pediatric HAE

Read more ››
By: Nasdaq / GlobenewsWire - 21 Jun 2018

Prosten Health Holdings Limited officially renamed as "China Brilliant Global Limited"

HONG KONG, June 21, 2018 /PRNewswire/ -- Prosten Health Holdings Limited ("the Company"; Stock code: 08026) is pleased to announce the Company has officially renamed as "China Brilliant Global Limited" (referred to as "China Brilliant") with effect from 20 June 2018.

Read more ››
By: PR Newswire Association LLC. - 21 Jun 2018

Patient Safety Offers Lucrative Prospects for Innovative Solutions Providers, says Frost and Sullivan

SINGAPORE, June 21, 2018 /PRNewswire/ -- Adverse patient safety events in the US and Western European healthcare systems impose an estimated cost burden of US$ 317.93 billion in 2016 and is estimated to increase at a CAGR of 3.2% reaching US$ 383.7 billion in 2022. The rising incidences of adverse... Read more ››

By: PR Newswire Association LLC. - 21 Jun 2018
Related companies:  FROST & SULLIVAN, BANGALORE | Frost & Sullivan | Frost & Sullivan, Australia

Alligator Bioscience's ATOR-1017 Strongly Activates Both T cells and NK Cells, Important for the Effective Eradication of Tumor Cells

LUND, Sweden, June 21, 2018 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 21 Jun 2018
Related companies:  Alligator Bioscience AB

Capio Appoints Attila Vegh as New CEO

GÖTHENBURG, Sweden, June 21, 2018 /PRNewswire/ -- The Board of Directors of Capio AB has today appointed Attila Vegh as the new President and CEO for Capio AB. He is currently CEO of Penta Hospitals International, the leading hospital chain in Central and Eastern Europe. Attila Vegh will... Read more ››

By: PR Newswire Association LLC. - 21 Jun 2018
Related companies:  Capio S:t Görans Sjukhus | Capio AB

SciBase Releases Major Improvements to Nevisense

STOCKHOLM, June 21, 2018 /PRNewswire/ -- The previously announced breakthrough update to Nevisense, SciBase device for the early detection of melanoma, has now been released.

Read more ››
By: PR Newswire Association LLC. - 21 Jun 2018
Related companies:  SCIBASE HOLDING AB

Aptinyx Announces Pricing of Initial Public Offering

EVANSTON, Ill., June 20, 2018 /PRNewswire/ -- Aptinyx Inc. (NASDAQ:APTX), a clinical-stage biopharmaceutical company developing transformative therapies for challenging neurologic disorders, today announced the pricing of its initial public offering of 6,399,999 shares of its common stock at... Read more ››

By: PR Newswire Association LLC. - 21 Jun 2018
Related companies:  Aptinyx Inc.

Xeris Pharmaceuticals Announces Pricing of Initial Public Offering of Common Stock

Read more ››
By: Nasdaq / GlobenewsWire - 21 Jun 2018

Ramzan M. Zakir, M.D., F.A.CC., FSCAI is recognized by Continental Who's Who

NEW BRUNSWICK, N.J., June 20, 2018 /PRNewswire/ -- Ramzan M. Zakir, M.D., F.A.CC., FSCAI is recognized by Continental Who's Who as 2018 Cardiologist of The Year in the field of Medicine in recognition of his role as Interventional Cardiologist at Heart & Vascular Institute of Central New... Read more ››

By: PR Newswire Association LLC. - 21 Jun 2018

Kezar Life Sciences Announces Pricing of Initial Public Offering

SOUTH SAN FRANCISCO, Calif., June 20, 2018 /PRNewswire/ -- Kezar Life Sciences, Inc. (Nasdaq:KZR), a clinical-stage biotechnology company discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer, announced today that it has priced its initial... Read more ››

By: PR Newswire Association LLC. - 21 Jun 2018
Related companies:  KEZAR LIFE SCIENCES, INC.

Oncobiologics Announces Conversion of Majority of Series A Convertible Preferred Stock

Read more ››
By: Nasdaq / GlobenewsWire - 20 Jun 2018

Two Publications Recognize NovuHealth as a Top Workplace in Minnesota

Read more ››
By: Nasdaq / GlobenewsWire - 20 Jun 2018

The nuclear medicine market is projected to grow at a CAGR of 5.9%

LONDON, June 20, 2018 /PRNewswire/ -- The nuclear medicine market is projected to grow at a CAGR of 5.9%
The nuclear medicine market is projected to reach USD 5.26 billion by 2023 from USD 3.95 billion in 2018. Factors such as the growing incidence and prevalence of cancer and cardiac... Read more ››

By: PR Newswire Association LLC. - 20 Jun 2018

Global Hearing Protection Devices Markets 2016-2024: Recent Industry Activity, Product Innovations, Key Growth Drivers, Competition & Trends

DUBLIN, June 20, 2018 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 20 Jun 2018

PATH and SD BIOSENSOR announce partnership to advance diagnostic test critical for malaria treatment and elimination

Agreement supports development and availability of an affordable, high-quality enzyme deficiency test

Read more ››
By: PR Newswire Association LLC. - 20 Jun 2018
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Explore our database of over 50,000 companies